Biolex Therapeutics - LEX System's Unit Acquisition

Biolex Therapeutics - LEX System raised a round of funding on April 21, 2012. Investors include Synthon.

Biolex Therapeutics is a clinical-stage biopharmaceutical company that uses the LEX System to develop follow-on biologics, hard-to-make therapeutic proteins and monoclonal antibodies that have been op…

Articles about Biolex Therapeutics - LEX System's Unit Acquisition: